The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGILE THERAPEUTICS INC | COM | 00847L100 | 6,529 | 3,510,189 | SH | SOLE | 3,510,189 | 0 | 0 | ||
| NASDAQ INC | COM | 631103108 | 1,841,474 | 19,394,142 | SH | SOLE | 19,394,142 | 0 | 0 | ||
| NEURONETICS INC | COM | 64131A105 | 3,391 | 1,794,228 | SH | SOLE | 1,794,228 | 0 | 0 | ||
| HOLLYSYS AUTOMATION TECHNOLO | COM | G45667105 | 387 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||